Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for thrombocytopenia in low or Intermediate-1 risk myelodysplastic syndrome
2007-007258-75Phase 2Completed
- Sponsor
- Amgen
- Start
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myelodysplastic syndrome (MDS) comparing Romiplostim with Placebo (2 arms). Primary endpoint: Incidence of clinically significant bleeding events. Started Jun 2008; status: completed.
02
Drugs
romiplostim
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on 2007-007258-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007258-75.